Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Piercer of microtubule wall 1 protein (PIERCE1) is a microtubule inner protein involved in the structural organization of the cilia axoneme, specifically facilitating the attachment of outer dynein arms to dynein-decorated doublet microtubules[4]. The protein plays roles in axoneme assembly, establishment of developmental left/right asymmetry, and sperm motility. PIERCE1 is also predicted to participate in DNA damage response and regulation of gene expression pathways, although these functions are less well characterized. Mutations in PIERCE1 are associated with human ciliopathies such as Meckel syndrome (type 2) and Bardet-Biedl syndrome 3[4]. Do not conflate PIERCE1 with PRC1, the protein regulator of cytokinesis 1. PRC1 is a microtubule-associated protein crucial for mitotic spindle organization and cytokinesis[1][2][3]; while PIERCE1 is primarily linked to ciliary microtubule function[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Piercer of microtubule wall 1 protein (PIERCE1).